SOURCE: Healthnostics, Inc.

May 18, 2011 08:38 ET

Healthnostics Addresses Unusual Trading

NEW YORK, NY--(Marketwire - May 18, 2011) - Healthnostics, Inc. (PINKSHEETS: HNSS) previously issued guidance regarding short-sales of Healthnostics, Inc. common stock. At that time there was strong circumstantial evidence indicating a sizable short position in the stock. Unusual trading activity has continued, involving new market-makers and a significant increase in volume, likely including illegal naked short selling. The Company is investigating this activity, and reports of current market-maker positions and shareholder listings are being requested.

However, the best defenses against short-selling are strong fundamentals, which Healthnostics' unfolding business plan continues to support. This will be validated when the Initial Information and Disclosure Document for filing on the OTC Market reporting system is filed later this quarter.

In the opinion of management, the Company's reported earnings, earnings guidance, and product development indicate that the current price of the stock is significantly undervalued.

About Healthnostics

Healthnostics, Inc. is a diversified manufacturer, system manufacturer, product distribution, and consulting company, including subsidiaries Microfill Corporation, Worldwide Wipes Co. and HNS Fund Co.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information

  • Contact:
    Healthnostics, Inc.
    Investor Relations
    P. 301-956-3342
    Email Contact